TMCnet News

HIV Forecast in 8 Major Markets Report 2016-2026 - Analysis, Technologies & Forecasts - Research and Markets
[September 30, 2016]

HIV Forecast in 8 Major Markets Report 2016-2026 - Analysis, Technologies & Forecasts - Research and Markets


Research and Markets has announced the addition of the "HIV Forecast in 8 Major Markets 2016-2026" report to their offering.

This report provides the current prevalent population for HIV across 8 Major Markets (USA, France, Germany, Italy, Spain, UK, Brazil and Japan) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

This report is built using data and information sourced from the proprietary patient segmentation database. To generate accurate patient population estimates, the database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been idetified in the report.



Reasons to Buy:

  • Able to quantify patient populations in global HIV market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of HIV and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on the HIV prevalent population.
  • Identify sub-populations within HIV which require treatment.

Report Structure:


1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis (News - Alert) & Clinical Course

7. Key comorbid conditions/Features associated with the disease

8. Methodology for quantification of patient numbers

9. Top-line prevalence for HIV

10. Characteristics of HIV patients

11. Abbreviations used in the report

12. Patient-Based Offering

13. Online Pricing Data and Platforms

14. References

15. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/sxq552/hiv_forecast_in_8


[ Back To TMCnet.com's Homepage ]